Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study.
Lin WC, Tai WC, Chang CH, Tu CH, Feng IC, Shieh MJ, Chung CS, Yen HH, Chou JW, Wong JM, Liu YH, Huang TY, Chuang CH, Tsai TJ, Chiang FF, Lu CY, Hsu WH, Yu FJ, Chao TH, Wu DC, Ho AS, Lin HH, Feng CL, Wu KL, Wong MW, Tung CC, Lin CC, Chen CC, Hu HM, Lu LS, Wang HS, Wu IC, Kuo HY, Wu JF, Yao Shih H, Ni YH, Tang SL, Chen PH, Wei SC. Lin WC, et al. Among authors: tsai tj. Inflamm Bowel Dis. 2023 Nov 2;29(11):1730-1740. doi: 10.1093/ibd/izac269. Inflamm Bowel Dis. 2023. PMID: 36626567 Free PMC article.
Eight weeks of esomeprazole therapy reduces symptom relapse, compared with 4 weeks, in patients with Los Angeles grade A or B erosive esophagitis.
Hsu PI, Lu CL, Wu DC, Kuo CH, Kao SS, Chang CC, Tai WC, Lai KH, Chen WC, Wang HM, Cheng JS, Tsai TJ, Chuah SK. Hsu PI, et al. Among authors: tsai tj. Clin Gastroenterol Hepatol. 2015 May;13(5):859-66.e1. doi: 10.1016/j.cgh.2014.09.033. Epub 2014 Sep 20. Clin Gastroenterol Hepatol. 2015. PMID: 25245625 Clinical Trial.
Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.
Hsu PI, Wu DC, Tsay FW, Cheng JS, Liu CP, Lai KH, Chen WC, Wang HM, Tsai TJ, Tsai KW, Kao SS. Hsu PI, et al. Among authors: tsai kw, tsai tj. Am J Gastroenterol. 2017 Feb;112(2):282-289. doi: 10.1038/ajg.2016.526. Epub 2016 Dec 6. Am J Gastroenterol. 2017. PMID: 27922030 Clinical Trial.
Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial.
Hsu PI, Tsay FW, Graham DY, Tsai TJ, Tsai KW, Kao JY, Peng NJ, Kuo CH, Kao SS, Wang HM, Lin TF, Wu DC; Taiwan Acid-related Disease (TARD) Study Group. Hsu PI, et al. Among authors: tsai kw, tsai tj. Clin Gastroenterol Hepatol. 2018 Sep;16(9):1427-1433. doi: 10.1016/j.cgh.2018.03.031. Epub 2018 Mar 31. Clin Gastroenterol Hepatol. 2018. PMID: 29609070 Clinical Trial.
Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
Hsu PI, Pan CY, Kao JY, Tsay FW, Peng NJ, Kao SS, Wang HM, Tsai TJ, Wu DC, Chen CL, Tsai KW; Taiwan Acid-related Disease (TARD) Study Group. Hsu PI, et al. Among authors: tsai kw, tsai tj. Helicobacter. 2018 Aug;23(4):e12498. doi: 10.1111/hel.12498. Epub 2018 Jun 13. Helicobacter. 2018. PMID: 29897654
Equivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infection.
Hsu PI, Tsay FW, Kao JY, Peng NJ, Tsai KW, Tsai TJ, Kuo CH, Kao SS, Wang HM, Chen YH, Shie CB, Wu DC; Taiwan Acid-related Disease & Microbiota (TARD-M) Consortium. Hsu PI, et al. Among authors: tsai kw, tsai tj. J Gastroenterol Hepatol. 2020 Oct;35(10):1731-1737. doi: 10.1111/jgh.15034. Epub 2020 Mar 31. J Gastroenterol Hepatol. 2020. PMID: 32167605 Free article. Clinical Trial.
Meckel's Diverticulum Diagnosed by Balloon-Assisted Enteroscopy: A Multicenter Report from the Taiwan Association for the Study of Small Intestinal Diseases (TASSID).
Chou JW, Chung CS, Huang TY, Tu CH, Chang CW, Chang CH, Wang YP, Hsu WH, Yen HH, Kuo CJ, Chuang CH, Lin CP, Tsai TJ, Su MY, Wang HY, Wu DC, Chiu CT. Chou JW, et al. Among authors: tsai tj. Gastroenterol Res Pract. 2021 Nov 18;2021:9574737. doi: 10.1155/2021/9574737. eCollection 2021. Gastroenterol Res Pract. 2021. PMID: 34840565 Free PMC article.
294 results